Total Payments
$485,269
2024 Payments
$92,620
Companies
32
Transactions
345
Payment Breakdown by Category
Consulting$312,705 (64.4%)
Other$96,598 (19.9%)
Travel$41,464 (8.5%)
Research$27,293 (5.6%)
Food & Beverage$6,821 (1.4%)
Education$389.43 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $312,705 | 50 | 64.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,865 | 29 | 15.8% |
| Travel and Lodging | $41,464 | 73 | 8.5% |
| Unspecified | $27,293 | 35 | 5.6% |
| Honoraria | $19,733 | 12 | 4.1% |
| Food and Beverage | $6,821 | 136 | 1.4% |
| Education | $389.43 | 10 | 0.1% |
Payments by Type
General
$457,977
310 transactions
Research
$27,293
35 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $228,705 | 20 | $0 (2024) |
| PFIZER INTERNATIONAL LLC | $107,059 | 79 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $42,357 | 36 | $0 (2024) |
| Novo Nordisk Inc | $29,871 | 49 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $19,568 | 27 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $16,055 | 22 | $0 (2022) |
| Novo Nordisk AS | $9,388 | 8 | $0 (2019) |
| Tolmar, Inc. | $8,868 | 16 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $7,166 | 14 | $0 (2017) |
| Ascendis Pharma Inc | $6,494 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92,620 | 62 | PFIZER INTERNATIONAL LLC ($43,539) |
| 2023 | $78,805 | 47 | OPKO Pharmaceuticals, LLC ($44,250) |
| 2022 | $134,698 | 66 | OPKO Pharmaceuticals, LLC ($91,200) |
| 2021 | $49,227 | 17 | OPKO Pharmaceuticals, LLC ($36,037) |
| 2020 | $56,991 | 13 | OPKO Pharmaceuticals, LLC ($49,218) |
| 2019 | $26,811 | 59 | Novo Nordisk Inc ($7,266) |
| 2018 | $17,465 | 29 | Novo Nordisk AS ($8,018) |
| 2017 | $28,652 | 52 | Endo Pharmaceuticals Inc. ($12,309) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/19/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/17/2024 | PFIZER INC. | NGENLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/16/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Achondroplasia | ||||||
| 12/13/2024 | PFIZER INC. | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $1,018.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 12/09/2024 | PFIZER INC. | NGENLA (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: NGENLA CLINICAL PUBLICATION PROGRAM • Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/08/2024 | PFIZER INC. | NGENLA (Drug) | — | In-kind items and services | $330.00 | Research |
| Study: NGENLA CLINICAL PUBLICATION PROGRAM • Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/06/2024 | PFIZER INTERNATIONAL LLC | GENOTROPIN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 11/17/2024 | PFIZER INC. | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $3,423.90 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 11/16/2024 | PFIZER INC. | NGENLA (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: NGENLA CLINICAL PUBLICATION PROGRAM • Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/07/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $209.00 | General |
| Category: Achondroplasia | ||||||
| 11/07/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $130.71 | General |
| Category: Achondroplasia | ||||||
| 11/07/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $69.83 | General |
| Category: Achondroplasia | ||||||
| 11/07/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $34.19 | General |
| Category: Achondroplasia | ||||||
| 11/06/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Achondroplasia | ||||||
| 11/04/2024 | PFIZER INTERNATIONAL LLC | GENOTROPIN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,750.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 10/31/2024 | PFIZER INC. | NGENLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/24/2024 | PFIZER INTERNATIONAL LLC | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $334.42 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 10/17/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $5,876.38 | General |
| Category: Achondroplasia | ||||||
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $842.01 | General |
| Category: Achondroplasia | ||||||
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $272.49 | General |
| Category: Achondroplasia | ||||||
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.11 | General |
| 09/12/2024 | PFIZER INTERNATIONAL LLC | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $690.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SOMATROGON CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $13,090 | 19 |
| MOD4023 OPKO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,650 | 6 |
| TOL2581A | TOLMAR, INC. | $2,763 | 3 |
| NGENLA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $2,540 | 4 |
| TOL2581A-CPP | TOLMAR, INC. | $2,250 | 3 |
About Dr. Lawrence Silverman, MD
Dr. Lawrence Silverman, MD is a Pediatric Endocrinology healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336113653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Silverman, MD has received a total of $485,269 in payments from pharmaceutical and medical device companies, with $92,620 received in 2024. These payments were reported across 345 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($312,705).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Morristown, NJ
- Active Since 02/14/2006
- Last Updated 09/11/2007
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1336113653
Products in Payments
- RAYALDEE (Drug) $49,218
- NGENLA (Drug) $45,533
- GENOTROPIN (Drug) $35,343
- VOXZOGO 1.2mg (Drug) $30,212
- Norditropin (Drug) $20,120
- FENSOLVI (Drug) $16,359
- SUPPRELIN LA (Drug) $12,360
- Norditropin (Biological) $9,097
- SUPPRELIN (Drug) $7,208
- Triptodur (Drug) $7,166
- SKYTROFA (Drug) $6,388
- ELIGARD (Drug) $3,471
- ZOMACTON (Drug) $2,875
- TOL2581A (Drug) $2,763
- Eligard 45mg and CPP (Drug) $2,250
- Thyquidity (Drug) $1,800
- LUPRON DEPOT (Drug) $1,240
- Sogroya (Biological) $475.76
- Minimed 670G System (Device) $208.35
- TZIELD (Biological) $127.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Morristown
Daisy Chin, Md, MD
Pediatric Endocrinology — Payments: $7,554
Pediatric Endocrinology $7,554
Barbara Cerame, Md, MD
Pediatric Endocrinology — Payments: $5,308
Pediatric Endocrinology $5,308
Melissa Woo, Md, MD
Pediatric Endocrinology — Payments: $1,026
Pediatric Endocrinology $1,026
Harold Starkman, Md, MD
Pediatric Endocrinology — Payments: $808.24
Pediatric Endocrinology $808.24
Dr. Tymara Berry, M.d, M.D
Pediatric Endocrinology — Payments: $52.88
Pediatric Endocrinology $52.88
Tejal Patel, Do, DO
Pediatric Endocrinology
Pediatric Endocrinology